Intrahepatic cholangiocarcinoma patient with epidermal growth factor receptor exon 19 deletion unresponsive to Afatinib monotherapy: a case report

Abstract Background The efficacy of epidermal growth factor receptor EGFR tyrosine kinase inhibitors in cholangiocarcinoma (CCA) patients is still unknown. Here, we report a 67-year-old CCA patient with EGFR exon 19 deletion receiving afatinib treatment. Case description A 67-year-old male was refer...

Descrición completa

Detalles Bibliográficos

Principais autores:	Caijiu Deng, Junming Huang, Qian Yu, Jianjun Han, Yuanxue Jiang, Liping Lin, Xiaolong Cao
Formato:	Artigo
Idioma:	Inglês
Publicado:	Springer 2025-04-01
Series:	Discover Oncology
Assuntos:	Cholangiocarcinoma Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) EGFR exon 19 deletion Afatinib
Acceso en liña:	https://doi.org/10.1007/s12672-025-02271-2
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!